FDA Probes Monster Beverages
The Food and Drug Administration has confirmed that it is investigating reports that five people since 2009 may have died after consuming Monster Beverage Corp. drinks.
The probe is based on incident reports that doctors and companies voluntarily submit to the FDA. The FDA told Bloomberg that the incidents are considered to be allegations, and no conclusion is drawn until an investigation is completed.
Last week, the parents of a 14-year-old Maryland teenager, Anais Fournier, filed a civial suit in Calfornia against Corona, Calif.-based Monster, alleging that their daughter died from "caffeine toxicity" after consuming two, 24-ounce cans of Monster energy drinks, according to The Wall Street Journal, which reported that Fournier had a preexisting heart problem.
Monster released a statement saying it does not believe that its drinks are responsible for the teen's death, and is unaware of "any fatality anywhere that has been caused by its drinks." Its labels warn that the drinks aren't recommended for children or those sensitive to caffeine, but do not specify their caffeine content.
Last month, Sens. Dick Durbin (D., Ill.) and Richard Blumenthal (D., Conn.) asked the FDA to investigate the safety of energy drinks, and consider limiting the caffeine allowed in such beverages. Last year, the Substance Abuse and Mental Health Services Administration issued a report showing that emergency-room visits involving energy drinks had increased tenfold between 2005 and 2009.
For regulatory purposes, energy drinks are considered dietary supplements. The FDA said that it continues to evaluate the emerging science on caffeine and other ingredients. It is also working on guidelines relating to dietary supplements and beverages. In 2009, the U.S. Government Accountability Office recommended that the FDA act to take greater oversight of dietary supplements, including energy drinks.
As previously reported, New York attorney general Eric T. Schneiderman issued subpoenas in July to PepsiCo (AMP), Monster Beverage Corp. and Living Essentials (5-hour Energy), asking for information on their marketing and advertising practices, in an investigation of whether their marketing may be deceptive.
Recent Raw Articles
-
Report: Yahoo Formally Bids On Hulu May 24, 3:38 p.m.
Yahoo has submitted a formal bid to acquire Hulu, according to a Reuters report citing two ...
-
Pandora Beats Q1 Revenue Estimate May 23, 5:22 p.m.
Online radio service Pandora on Thursday reported revenue rose 55% in the first quarter to $126 ...
-
Digital Diva Bradford To Helm S.F. Chronicle May 23, 4:41 p.m.
Digital media sales vet Joanne Bradford Joins has joined Hearst's San Francisco Chronicle as president. She ...
-
Y&R, 90 Years Young, Digitally Celebrates In Times Square Today May 23, 1:03 p.m.
A 90-year old ad agency is using some new-fangled technology to celebrate today in real time ...
-
Opera Extends Ad Tools To Connected TV May 22, 1:23 p.m.
After tackling the desktop, and then mobile, Opera lately has been expanding into the emerging realm ...
-
Former NBC Sales Chief Gambelli Succeeds Cohen As Horizon's Chief Investment Officer May 21, 3:19 p.m.
Former NBC sales chief Marianne Gambelli is joining Horizon Media as executive vice president-Chief Investment Officer, ...
-
Fidelity Turns ATM Into Dance Machine May 21, 2:27 p.m.
Who says Fidelity isn’t fun? Speaking at OMMA Social, the investment firm’s digital marketing head Chris ...
-
Outdoor Industry Launches 'Commercial Ratings' Initiative, Will Measure Eyes On Digital Ads May 21, 10:36 a.m.
The out-of-home media industry is poised to begin developing new research to develop "commercial ratings" for ...
-
Yahoo Confirms Tumblr Acquisition For $1.1 Billion May 20, 8:42 a.m.
Yahoo on Monday confirmed it will buy blogging service Tumblr for $1.1 billion in cash. The ...
-
Yahoo Adds Tweets To News Feed May 16, 1:25 p.m.
Yahoo will incorporate selected tweets into the news feed on its redesigned home page through a ...


Be the first to comment on "FDA Probes Monster Beverages"
Leave a Comment